Safety and efficacy of galantamine in subjects with mild cognitive impairment.
OBJECTIVE: To assess the safety of galantamine in subjects with mild cognitive impairment (MCI), the ability of galantamine to benefit cognition and global functioning in subjects with MCI, and the ability of galantamine to delay conversion to dementia. METHODS: In two studies, 2,048 subjects, 990...
Main Authors: | Winblad, B, Gauthier, S, Scinto, L, Feldman, H, Wilcock, G, Truyen, L, Mayorga, A, Wang, D, Brashear, H, Nye, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
by: Pirttilä, T, et al.
Published: (2004) -
Long-term safety, tolerability and efficacy of galantamine: Results from a 36-month analysis of extension study data
by: Wilcock, G, et al.
Published: (2002) -
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
by: Wilcock, G, et al.
Published: (2000) -
Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies
by: Wilcock, G, et al.
Published: (2002) -
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000)
by: Wilcock, G
Published: (2001)